IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2022 Holdings

Filed 2022-11-14 | 11 holdings | $189.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$171.7M643,00090.4%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$17.5M1,390,7909.2%
Alkermes PLC(ALKS)SHSG01767105$313.5K14,040,0000.2%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$169.8K16,390,0000.1%
Gilead Sciences Inc(GILD)COM375558103$78.5K1,273,1000.0%
Innoviva Inc(INVA)COM45781M101$76.8K6,614,0000.0%
Mersana Therapeutics IncCOM59045L106$27.0K3,997,0100.0%
Amarin Corp PLCSPONS ADR NEW023111206$26.2K23,998,0000.0%
VOR Biopharma IncCOM929033108$2.5K618,0000.0%
Pear Therapeutics IncCLASS A COM704723105$1.0K500,3560.0%
Regulus Therapeutics Inc(RGLS)COM75915K309$315185,1830.0%